Idera Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Aceto ACET:US 0 0
Agenus AGEN:US $ 19.78M 0.59M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
Biogen BIIB:US $ 7271.1M 1.9M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cytrx CYTR:US 0 0
Dynavax Technologies DVAX:US $ 219.96M 40.07M
Eli Lilly And LLY:US $ 16515.1M 310.6M
GlaxoSmithKline GSK:LN 25483M 736M
Idera Pharmaceuticals IDRA:US $ 0M 0M
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M